Publications: Gilmore, Grace

Journal Article

Gilmore, G., Baker, R. and Tiao, J. (2022) 289.1 Evaluation of a rapid screening test as an effective tool in decentralizing ADAMTS13 activity testing - report from the rapid assessment of plasma in microangiopathic thrombocytopenia (RAPMAT) study. Research and Practice in Thrombosis and Haemostasis, 6 (S1). PB0292.

Tian, J.ORCID: 0000-0001-9887-7211, Adams, M.J.ORCID: 0000-0002-7743-4515, Tay, J.W.T., James, I., Powell, S., Hughes, Q.W., Gilmore, G., Baker, R.I. and Tiao, J.Y-H. (2021) Estradiol-responsive miR-365a-3p interacts with tissue factor 3′UTR to modulate tissue factor-initiated thrombin generation. Thrombosis and Haemostasis, 121 (11). pp. 1483-1496.

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interference. Clinical Chemistry and Laboratory Medicine, 58 (8).

Favaloro, E.J., Gilmore, G., Bonar, R., Dean, E., Arunachalam, S., Mohammed, S. and Baker, R. (2020) Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effects. Haemophilia . Early View.

Tiao, J., Powell, S., Gilmore, G., Veedu, R., Wilton, S. and Baker, R. (2020) Splice inducing Antisense Oligonucleotides as a potential gene correction therapy for haemophilia A. Haemophilia, 26 (S4). pp. 21-22.

Favaloro, E., Gilmore, G., Arunachalam, S., Mohammed, S. and Baker, R. (2019) Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa. Thrombosis Research, 180 . pp. 10-19.

Baker, R., Gilmore, G., Jorritsma, J., Hughes, Q., Tiao, J. and Tay, J. (2017) Circulating MicroRNA as thrombosis sentinels: Caveats and considerations. Seminars in Thrombosis and Hemostasis, 44 (3). pp. 206-215.

Tay, J., Tiao, J., Hughes, Q., Gilmore, G. and Baker, R. (2016) Therapeutic Potential of miR-494 in Thrombosis and Other Diseases: A Review. Australian Journal of Chemistry, 69 (10). pp. 1078-1093.

Adams, M.J.ORCID: 0000-0002-7743-4515, Thom, J., Hankey, G.J., Baker, R., Gilmore, G., Staton, J. and Eikelboom, J.W. (2006) The tissue factor pathway in ischemic stroke. Blood Coagulation & Fibrinolysis, 17 (7). pp. 527-532.